Suppr超能文献

相似文献

3
Neural control of the anorexia-cachexia syndrome.
Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1000-8. doi: 10.1152/ajpendo.90252.2008. Epub 2008 Aug 19.
4
Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling.
Curr Opin Nephrol Hypertens. 2007 Jan;16(1):27-31. doi: 10.1097/MNH.0b013e3280117ce7.
5
7
Cytokines and cancer anorexia cachexia syndrome.
Am J Hosp Palliat Care. 2008 Oct-Nov;25(5):407-11. doi: 10.1177/1049909108315518. Epub 2008 Apr 10.
8
Cachexia and neuropeptide Y.
Nutrition. 2008 Sep;24(9):815-9. doi: 10.1016/j.nut.2008.06.020.
9
Contribution of anorexia to tissue wasting in cachexia.
Curr Opin Support Palliat Care. 2010 Dec;4(4):249-53. doi: 10.1097/SPC.0b013e32833e4aa5.
10
Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement.
Int J Cardiol. 2007 Jun 25;119(1):83-9. doi: 10.1016/j.ijcard.2006.07.088. Epub 2006 Oct 24.

引用本文的文献

1
Progress in the study of nutritional status and selenium in dialysis patients.
Ann Med. 2023 Dec;55(1):2197296. doi: 10.1080/07853890.2023.2197296.
3
Pathophysiological mechanisms leading to muscle loss in chronic kidney disease.
Nat Rev Nephrol. 2022 Mar;18(3):138-152. doi: 10.1038/s41581-021-00498-0. Epub 2021 Nov 8.
4
Altered Emotional Phenotypes in Chronic Kidney Disease Following 5/6 Nephrectomy.
Brain Sci. 2021 Jun 30;11(7):882. doi: 10.3390/brainsci11070882.
5
Meta-Analysis of Clinical Efficacy and Safety of Polyglycosides Tablets in the Treatment of Chronic Kidney Disease.
Evid Based Complement Alternat Med. 2021 May 13;2021:6640594. doi: 10.1155/2021/6640594. eCollection 2021.
6
Malnutrition in Chronic Kidney Disease.
Front Pediatr. 2018 Jun 20;6:161. doi: 10.3389/fped.2018.00161. eCollection 2018.
7
Nutritional treatment of advanced CKD: twenty consensus statements.
J Nephrol. 2018 Aug;31(4):457-473. doi: 10.1007/s40620-018-0497-z. Epub 2018 May 24.
8
Muscle wasting in chronic kidney disease.
Pediatr Nephrol. 2018 May;33(5):789-798. doi: 10.1007/s00467-017-3684-6. Epub 2017 May 15.
9
Neuropeptide Y levels are associated with nutritional status and cardiovascular events in adults with chronic kidney disease.
Eur J Clin Nutr. 2015 Jun;69(6):717-21. doi: 10.1038/ejcn.2015.67. Epub 2015 Apr 29.
10
Hormonal regulation of energy-protein homeostasis in hemodialysis patients: an anorexigenic profile that may predispose to adverse cardiovascular outcomes.
Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E55-64. doi: 10.1152/ajpendo.00438.2010. Epub 2010 Oct 19.

本文引用的文献

1
Role of leptin and melanocortin signaling in uremia-associated cachexia.
J Clin Invest. 2005 Jun;115(6):1659-65. doi: 10.1172/JCI22521.
4
Malnutrition: a frequent misdiagnosis for hemodialysis patients.
J Clin Invest. 2002 Aug;110(4):437-9. doi: 10.1172/JCI16494.
5
Gut hormone PYY(3-36) physiologically inhibits food intake.
Nature. 2002 Aug 8;418(6898):650-4. doi: 10.1038/nature00887.
6
Obesity: keeping hunger at bay.
Nature. 2002 Aug 8;418(6898):595-7. doi: 10.1038/418595a.
7
Hypothalamic peptides as drug targets for obesity.
Curr Opin Pharmacol. 2001 Dec;1(6):651-5. doi: 10.1016/s1471-4892(01)00110-2.
8
Leptin regulation of the immune response and the immunodeficiency of malnutrition.
FASEB J. 2001 Dec;15(14):2565-71. doi: 10.1096/fj.01-0431rev.
10
Role of the central melanocortin system in cachexia.
Cancer Res. 2001 Feb 15;61(4):1432-8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验